These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 20006791)

  • 1. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.
    Vlassara H; Uribarri J; Ferrucci L; Cai W; Torreggiani M; Post JB; Zheng F; Striker GE
    Semin Nephrol; 2009 Nov; 29(6):594-603. PubMed ID: 20006791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging.
    Vlassara H; Torreggiani M; Post JB; Zheng F; Uribarri J; Striker GE
    Kidney Int Suppl; 2009 Dec; (114):S3-11. PubMed ID: 19946325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.
    Vlassara H; Cai W; Goodman S; Pyzik R; Yong A; Chen X; Zhu L; Neade T; Beeri M; Silverman JM; Ferrucci L; Tansman L; Striker GE; Uribarri J
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4483-91. PubMed ID: 19820033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan.
    Cai W; He JC; Zhu L; Chen X; Zheng F; Striker GE; Vlassara H
    Am J Pathol; 2008 Aug; 173(2):327-36. PubMed ID: 18599606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.
    Torreggiani M; Liu H; Wu J; Zheng F; Cai W; Striker G; Vlassara H
    Am J Pathol; 2009 Oct; 175(4):1722-32. PubMed ID: 19779136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression.
    Cai W; He JC; Zhu L; Chen X; Wallenstein S; Striker GE; Vlassara H
    Am J Pathol; 2007 Jun; 170(6):1893-902. PubMed ID: 17525257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end product homeostasis: exogenous oxidants and innate defenses.
    Vlassara H; Uribarri J; Cai W; Striker G
    Ann N Y Acad Sci; 2008 Apr; 1126():46-52. PubMed ID: 18448795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.
    Uribarri J; Cai W; Ramdas M; Goodman S; Pyzik R; Chen X; Zhu L; Striker GE; Vlassara H
    Diabetes Care; 2011 Jul; 34(7):1610-6. PubMed ID: 21709297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials.
    Clarke RE; Dordevic AL; Tan SM; Ryan L; Coughlan MT
    Nutrients; 2016 Mar; 8(3):125. PubMed ID: 26938557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation.
    Cai W; He JC; Zhu L; Chen X; Striker GE; Vlassara H
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C145-52. PubMed ID: 18032526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and glycoxidant stress.
    Peppa M; Uribarri J; Vlassara H
    Hormones (Athens); 2008; 7(2):123-32. PubMed ID: 18477549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.
    Zhang Y; Lapidos KA; Gal-Moscovici A; Sprague SM; Ameer GA
    Artif Organs; 2014 Jun; 38(6):474-83. PubMed ID: 24206165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Rabbani N; Thornalley PJ
    Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.
    Uribarri J; Cai W; Peppa M; Goodman S; Ferrucci L; Striker G; Vlassara H
    J Gerontol A Biol Sci Med Sci; 2007 Apr; 62(4):427-33. PubMed ID: 17452738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.
    Cai W; Torreggiani M; Zhu L; Chen X; He JC; Striker GE; Vlassara H
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C624-34. PubMed ID: 19955485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.
    Linden E; Cai W; He JC; Xue C; Li Z; Winston J; Vlassara H; Uribarri J
    Clin J Am Soc Nephrol; 2008 May; 3(3):691-8. PubMed ID: 18256374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.
    Semba RD; Fink JC; Sun K; Windham BG; Ferrucci L
    J Ren Nutr; 2010 Mar; 20(2):74-81. PubMed ID: 19853477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.
    Vlassara H; Cai W; Chen X; Serrano EJ; Shobha MS; Uribarri J; Woodward M; Striker GE
    J Gerontol A Biol Sci Med Sci; 2012 Dec; 67(12):1410-6. PubMed ID: 23109677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between dietary and skin advanced glycation end products: the Rotterdam Study.
    Chen J; Waqas K; Tan RC; Voortman T; Ikram MA; Nijsten TEC; de Groot LCPGM; Uitterlinden AG; Zillikens MC
    Am J Clin Nutr; 2020 Jul; 112(1):129-137. PubMed ID: 32453418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.
    Cai W; Ramdas M; Zhu L; Chen X; Striker GE; Vlassara H
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15888-93. PubMed ID: 22908267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.